Sign in

CIK 0000730272

  • Large accelerated filer

REPLIGEN CORP

Sign in to watch
Ticker
RGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
042729386
Phone
+1 781-449-9560
Business address
41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,953,260
in 5 filings, $6.0M under 10b5-1 plans

Net −$5,953,260. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Loeillot Olivier −$6.0M Chief Executive Officer sold 41% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-08-11 KURIYEL RALF Senior VP, R&D Option exercise +646 $86.10 $56K 24,110
2022-08-11 KURIYEL RALF Senior VP, R&D Sale −800 $255.20 $204K 23,310
2022-08-11 KURIYEL RALF Senior VP, R&D Sale −4,040 $254.14 $1.0M 19,270
2022-08-11 KURIYEL RALF Senior VP, R&D Option exercise · Stock Option (Right to Buy) +2,000 0
2022-08-11 KURIYEL RALF Senior VP, R&D Option exercise · Stock Option (Right to Buy) +1,354 0
2022-08-11 KURIYEL RALF Senior VP, R&D Option exercise · Stock Option (Right to Buy) +646 400
2022-08-04 Gebski Christine See Remarks Sale −3,357 $243.01 $816K 30,735
2022-08-03 Bylund James Chief Operating Officer Option exercise +2,000 $94.33 $189K 11,733
2022-08-03 Bylund James Chief Operating Officer Sale −2,000 $240.40 $481K 9,733
2022-08-03 Bylund James Chief Operating Officer Option exercise · Stock Option (Right to Buy) −2,000 8,000
2022-08-01 Snodgres Jon Chief Financial Officer Sale −2,000 $220.00 $440K 37,187
2022-07-21 Hunt Anthony Chief Executive Officer Option exercise +5,000 $33.87 $169K 204,315
2022-07-21 Hunt Anthony Chief Executive Officer Option exercise +15,154 $32.40 $491K 219,469
2022-07-21 Hunt Anthony Chief Executive Officer Sale −24,802 $200.00 $5.0M 194,667
2022-07-21 Hunt Anthony Chief Executive Officer Option exercise · Stock Option (Right to Buy) +5,000 69,246
2022-07-21 Hunt Anthony Chief Executive Officer Option exercise · Stock Option (Right to Buy) +15,154 0
2022-05-26 Mhatre Rohin Director Grant or award +1,202 1,659
2022-05-26 Mhatre Rohin Director Grant or award · Stock Option (Right to Buy) +2,920 2,920
2022-05-26 Konstantinov Konstantin Director Grant or award +534 534
2022-05-26 Konstantinov Konstantin Director Grant or award · Stock Option (Right to Buy) +1,298 1,298

Page 19 of 23 · 455 trades